Meaningful extension of cash runway guidance from H2 2027 to H2 2028 following strategic decision to pursue partnership opportunities for naporafenib SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Erasca ...

outlining their plan to phase out animal testing requirement for monoclonal antibodies and other drugs with more human-relevant models. Our platform is best placed to serve current market gaps ...

outlining their plan to phase out animal testing requirement for monoclonal antibodies and other drugs with more human-relevant models. “Our platform is best placed to serve current market gaps ...

outlining their plan to phase out animal testing requirement for monoclonal antibodies and other drugs with more human-relevant models. Our platform is best placed to serve current market gaps ...

Organoids, miniaturized, stem cell-derived versions of human organs, are revolutionizing biomedical research by offering ...

VivoSim will offer liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of the FDA to phase out animal testing ...

Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based ...

In Brazil, researchers from the Federal University of Rio de Janeiro (UFRJ) and collaborators from the University of São ...